2020
DOI: 10.1038/s41392-020-0152-8
|View full text |Cite
|
Sign up to set email alerts
|

Hypoxia-induced GBE1 expression promotes tumor progression through metabolic reprogramming in lung adenocarcinoma

Abstract: Hypoxia mediates a metabolic switch from oxidative phosphorylation to glycolysis and increases glycogen synthesis. We previously found that glycogen branching enzyme (GBE1) is downstream of the hypoxia-inducible factor-1 (HIF1) signaling pathway in lung adenocarcinoma (LUAD) cells; however, the molecular mechanism underlying HIF1 regulation of GBE1 expression remains unknown. Herein, the effect of GBE1 on tumor progression via changes in metabolic signaling under hypoxia in vitro and in vivo was evaluated, and… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
55
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
2

Relationship

2
7

Authors

Journals

citations
Cited by 62 publications
(55 citation statements)
references
References 53 publications
0
55
0
Order By: Relevance
“…In various cancers, the expression of GPI is induced by c-Myc, and HIF-1 is overexpressed at the same time ( 43 , 44 ). HIF-1 can induce GBE1 upregulation, which would decrease CCL5 and CXCL10 secretion, hindering the recruitment of CD8+ T lymphocytes ( 45 , 46 ). GPI can also induce the protein expression of matrix metalloproteinase-3 and thereby promote the invasiveness of tumors ( 47 ).…”
Section: Discussionmentioning
confidence: 99%
“…In various cancers, the expression of GPI is induced by c-Myc, and HIF-1 is overexpressed at the same time ( 43 , 44 ). HIF-1 can induce GBE1 upregulation, which would decrease CCL5 and CXCL10 secretion, hindering the recruitment of CD8+ T lymphocytes ( 45 , 46 ). GPI can also induce the protein expression of matrix metalloproteinase-3 and thereby promote the invasiveness of tumors ( 47 ).…”
Section: Discussionmentioning
confidence: 99%
“…TFRC promotes the proliferation and metastasis of cancer cells by up-regulating the expression of AXIN2 to accelerate the progress of epithelial ovarian cancer (41). Transforming growth factor (TGFA) stimulates cell growth and proliferation, and its overexpression is associated with the survival rate of patients with many tumors (42 NFKB1 [ 7] XRCC6 [ 7] PGK1 [ 6] ENO1 [ 5] PFKP [ 5] TEK [ 5] SPP1 [ 4] TFRC [ 4] ADM [ 2] GAPDH [ 2] STC1 [ 2] DDIT3 [ 1] FGF3 [ 1] PLAUR [ 1] TGFA [ 1] EPAS1 [10] NFKB1 [ 7] XRCC6 [ 7] PGK1 [ 6] ENO1 [ 5] PFKP [ 5] TEK [ 5] SPP1 [ 4] TFRC [ 4] ADM [ 2] GAPDH [ 2] STC1 [ 2] DDIT3 [ 1] FGF3 [ 1] PLAUR [ 1] TGFA [ 1] * P < 0.001 NFKB1 [10] TEK [ 8] PFKP [ 5] STC1 [ 5] EPAS1 [ 4] PLAUR [ 4] TFRC [ 4] SPP1 [ 3] GAPDH [ 2] PGK1 [ 2]…”
Section: A B C Dmentioning
confidence: 99%
“…2.11 Transwell and wound-healing assays Transwell (8.0 µm pore size, Corning, USA) and wound-healing assays were used to detect the migration of tumor cells, which has been described detailedly in a previous paper [19].…”
Section: Cell Counting Kit-8 (Cck-8) and Colony Formation Assaysmentioning
confidence: 99%